Hemophilia gene therapy-New country initiatives.

Reiss, Ulrike M; Zhang, Lei; Ohmori, Tsukasa

Reiss, Ulrike M; Zhang, Lei; Ohmori, Tsukasa.

Afiliação

Reiss UM; Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Zhang L; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin Key Laboratory of Blood Disease Gene Therapy, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China.
Ohmori T; Department of Biochemistry, Jichi Medical University School of Medicine, Shimotsuke, Japan.

Haemophilia ; 27 Suppl 3: 132-141, 2021 Feb.

Article em En | MEDLINE | ID: mdl-32638467

Assuntos

Hemofilia A; Hemofilia B; China; Europa (Continente); Fator IX/genética; Fator VIII/genética; Terapia Genética; Hemofilia A/genética; Hemofilia A/terapia; Hemofilia B/genética; Hemofilia B/terapia; Humanos

Palavras-chave

China; Japan; gene therapy; global; haemophilia; low-and middle-income country

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Hemofilia B / Hemofilia A Limite: Humans País como assunto: Asia / Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google